Asgeirsson H

Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial.

Sundén-Cullberg J, Chen P, Häbel H, ..., Nowak P, Lampa J

PLoS One 18 (12) e0295838 [2023-12-29; online 2023-12-29]

Category: Health Funder: VR Type: Journal article

Comprehensive proteomics and meta-analysis of COVID-19 host response.

Babačić H, Christ W, Araújo JE, ..., Klingström J, Pernemalm M

Nat Commun 14 (1) 5921 [2023-09-22; online 2023-09-22]

Category: Other Category: Proteins Funder: KAW/SciLifeLab National COVID program Funder: VR Type: Journal article

Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.

Varnaitė R, García M, Glans H, ..., Klingström J, Gredmark-Russ S

J Immunol 205 (9) 2437-2446 [2020-11-01; online 2020-09-02]

Category: Biochemistry Category: Health Category: Proteins Funder: KAW/SciLifeLab National COVID program Funder: VR Research Area: Host cell systems biology and targets Type: Journal article